Tamoxifen: a caveat on the pro side of the debate.
| dc.contributor.author | Pressler, V M | |
| dc.date.accessioned | 2019-07-02T16:11:00Z | |
| dc.date.available | 2019-07-02T16:11:00Z | |
| dc.date.issued | 1993-04 | |
| dc.identifier.issn | 0017-8594 | |
| dc.identifier.pubmed | 8500989 | |
| dc.identifier.uri | http://hdl.handle.net/10524/62579 | |
| dc.language.iso | eng | |
| dc.subject.mesh | Adult | |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Breast Neoplasms/prevention & control | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Risk Factors | |
| dc.subject.mesh | Tamoxifen/adverse effects/therapeutic use | |
| dc.title | Tamoxifen: a caveat on the pro side of the debate. | |
| dc.type | Clinical Trial | |
| dc.type | Comment | |
| dc.type | Journal Article | |
| dc.type.dcmi | Text | |
| prism.number | 4 | |
| prism.pagerange | 90-4, 98 | |
| prism.publicationname | Hawaii medical journal | |
| prism.volume | 52 |
Files
Original bundle
1 - 1 of 1
